Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Block Admission & “At The Market” Sales Agreement

May 21, 2024
RNS Number : 1850P Renalytix PLC 21 May 2024   Renalytix plc ("Renalytix" or the "Company")   Block Admission and "At The Market" Sales Agreement LONDON and SALT LAKE CITY -   21 May 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   entered into an at-the-market offering agreement with H.C.

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 20, 2024
RNS Number : 0777P Stifel Nicolaus Europe Limited 20 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Form 8.3 - Renalytix plc

May 17, 2024
RNS Number : 9654O Renalytix PLC 17 May 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: DB Capital

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 17, 2024
RNS Number : 9105O Stifel Nicolaus Europe Limited 17 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/NON-RI) - RENALYTIX

May 16, 2024
RNS Number : 7255O Stifel Nicolaus Europe Limited 16 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 16, 2024
RNS Number : 7210O Stifel Nicolaus Europe Limited 16 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Renalytix Reports Financial Results for Q3 FY2024

May 15, 2024
RNS Number : 5079O Renalytix PLC 15 May 2024   Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024   LONDON and NEW YORK , May 15, 2024   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro

Holding(s) in Company

May 14, 2024
RNS Number : 3993O Renalytix PLC 14 May 2024   TR-1: Standard form for notification of major holdings Delayed announcement due to change in the holding as a results of placing as announced on the 12 March 2024 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2.

Holding(s) in Company

May 14, 2024
RNS Number : 3991O Renalytix PLC 14 May 2024   TR-1: Standard form for notification of major holdings Delayed announcement 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2. Reason for Notification An event changing the breakdown of voting rights 3.

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 14, 2024
RNS Number : 3323O Stifel Nicolaus Europe Limited 14 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of
Displaying 1 - 10 of 389